Physician profile
Anthony H Chavez
NPI 1104084029
$9,724.69
in general payments reported to CMS, 2019-2025
27 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,721 · 2020: $1,292 · 2021: $696 · 2022: $1,131 · 2023: $729 · 2024: $888 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,720 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.94 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,916.50 | 2019-2025 | |
| Astellas Pharma US INC | $635.24 | 2019-2024 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $602.30 | 2022-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $505.62 | 2024-2025 | Provenge |
| Myovant Sciences INC. | $322.85 | 2021-2022 | |
| Blue Earth Diagnostics | $248.57 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $220.97 | 2023-2024 | Orgovyx |
| Amgen INC. | $174.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $164.01 | 2019-2024 | |
| Tolmar Pharmaceuticals, INC. | $136.79 | 2020-2022 | |
| Hollister Incorporated | $92.50 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $91.11 | 2019-2023 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $72.89 | 2023-2024 | |
| Rochester Medical Corporation | $66.74 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $53.70 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $53.39 | 2021-2022 | |
| Abbvie INC. | $47.69 | 2021-2023 | Lupron Depot |
| Sun Pharmaceutical Industries INC. | $47.08 | 2022 | |
| Olympus America INC. | $40.99 | 2019-2020 | |
| Accord Healthcare, INC. | $38.40 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $37.16 | 2020 | |
| Boston Scientific Corporation | $36.62 | 2019-2023 | Spaceoar System |
| Convatec INC. | $33.07 | 2021 | |
| Coloplast Corp | $29.31 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $24.23 | 2023 | Givlaari |
| Novartis Pharmaceuticals Corporation | $16.95 | 2024 | |
| Progenics Pharmaceuticals, INC. | $15.58 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.